JA
EN
中文
1. Introduction: The Relationship Between Intellectual Disability and Chromosomal Abnormalities
Intellectual disability refers to a state in which the intelligence quotient (IQ) is below 70 and support is needed for daily life.
There are many causes, but congenital chromosomal abnormalities account for a significant portion.
In particular, in recent years it has become clear that “microdeletions / microduplications” (small missing or extra chromosome segments) can lead to intellectual disability or developmental disorders ranging from mild to severe.
2. What Are Chromosomal Abnormalities?
Chromosomal abnormalities are states in which the number or structure of chromosomes is altered. They are broadly classified into:
- Numerical abnormalities: an abnormal number of chromosomes (e.g., Down syndrome = trisomy 21)
- Structural abnormalities: parts of chromosomes are missing, duplicated, inverted, or translocated
Among structural abnormalities, extremely small deletions or duplications invisible to the naked eye are called microdeletions / microduplications, and these are difficult to detect with conventional chromosomal tests.
3. The Connection of Microdeletions / Duplications to Intellectual Disability
Recent genetic research has found that certain microdeletions/duplications are strongly associated with intellectual disability:
- 1p36 deletion syndrome
- 22q11.2 deletion syndrome (DiGeorge syndrome)
- 7q11.23 deletion syndrome (Williams syndrome)
- Abnormalities in the 15q11‑13 region (Prader–Willi syndrome / Angelman syndrome)
These can manifest in a spectrum from mild learning difficulties to severe intellectual disability, developmental disorders, or behavioral abnormalities, and are increasingly considered as part of prenatal diagnostic targets.
4. What Chromosomal Abnormalities Can Be Detected by NIPT
Traditional NIPT (non‑invasive prenatal testing) was focused on trisomies 21, 18, and 13, but in recent years screening has expanded to include whole‑chromosome testing and microdeletion syndromes.
By analyzing fetal DNA, the following information may be obtained before birth:
- Developmental risk due to microdeletions / duplications
- Risk of congenital anomalies from numerical abnormalities
- Predictions of medical/therapeutic support needs after birth
5. Why Even Small Abnormalities Can Have Major Impact
Microdeletions or duplications may involve only a few million base pairs (Mb) of chromosome material, yet these regions often contain genes critical for brain development.
For example, in 22q11.2 deletion syndrome, along with cardiac malformations or immune abnormalities, mild to moderate intellectual disability and psychiatric disorder risk are known.
Thus, even extremely small chromosomal anomalies can exert significant influence over neurodevelopment.
6. The Advantages of Knowing Before Birth
If small chromosomal abnormalities can be detected before birth, there are several benefits:
- Ability to arrange medical care immediately after birth
- Safe delivery in a facility with NICU (neonatal intensive care unit)
- Early initiation of therapeutic interventions and rehabilitation, enhancing developmental potential
- Time for the family to prepare psychologically
- Having this information helps reduce postnatal chaos and allows the child to get the best possible start
7. Limitations and Precautions of NIPT
Although NIPT is a convenient test, the following points must be noted:
- It is a screening test, not a definitive diagnosis
- If results are positive, confirmation via amniocentesis or chorionic villus sampling is required
- False positives or false negatives can rarely occur
- Individual acceptance of results varies; psychological support may be needed
8. Decision‑Making Processes for Families and Medical Providers
When prenatal testing suggests a chromosomal abnormality, families usually undertake the following steps to make decisions:
- Accurately understand the test results
- Decide whether to undergo confirmatory diagnostic testing (e.g. amniocentesis)
- Prepare for postnatal life, medical care, and education
Throughout this process, genetic counseling becomes highly important. Experts help interpret the meaning of results and alleviate the psychological burden on the family.
9. Social and Ethical Challenges
While early detection of chromosomal abnormalities is a medical advancement, it also brings the following challenges:
- Concern about societal pressure that “children with disabilities should not be born”
- Inequalities in test access due to geographic or economic disparity
- Psychological stress from information overload
Therefore, prenatal diagnosis should be considered not just as a source of medical information but in conjunction with a social support system.
10. Postnatal Support That Can Be Utilized
Even when small chromosomal abnormalities exist, proper medical care and support can significantly affect a child’s development:
- Early intervention programs (physical therapy, occupational therapy, speech therapy)
- Use of regional facilities and day programs for children with disabilities
- Comprehensive support through coordination of medical, educational, and welfare services
If risks are known prenatally, these supports can be initiated more smoothly and earlier.
11. Future Outlook
With advances in next‑generation sequencing technology, it will become possible to detect even smaller chromosomal abnormalities or gene‑level changes.
However, challenges in interpreting results and achieving societal acceptance remain, so a support system integrating medicine, ethics, and welfare is needed.
12. Impact of Early Detection of Chromosomal Abnormalities on Families
Knowing of possible chromosomal abnormalities before birth has not only medical advantages, but also significant effects on family psychology and life planning:
- Psychological readiness: obtaining information beforehand can reduce the shock of being told unexpectedly after birth
- Planning birth and child rearing: choosing the right obstetric facility and preparing neonatal medical care becomes possible
- Early utilization of social resources: learning in advance about support systems for children with disabilities, medical expense subsidies, and preparing application procedures
Thus, early detection is directly linked to improving not only the child’s but also the family’s quality of life.
13. Role of Genetic Counseling
In prenatal diagnostics, genetic counseling plays a key role. Genetic counselors and physicians provide the following support:
- Precise explanation of test methods and results
- Interpretation of medical significance and possible manifestations
- Support in decision‑making aligned with the family’s values
- Guidance on available social and therapeutic support systems
With this process, the family can sort through information and calmly decide on the next step.
14. Social and Ethical Considerations
As early detection of micro chromosomal abnormalities becomes more widespread, the following issues emerge:
- How to address the “pressure of choice” — whether the detection of an abnormality becomes a psychological burden regarding continuation of the pregnancy?
- How to correct information inequality — differences in access to tests and counseling between urban vs rural areas, among different economic strata
- How to improve societal acceptance and support for persons with disabilities?
Medical progress must proceed in tandem with support systems and ethical reflection.
15. Concrete Examples of Postnatal Medical & Therapeutic Care
For children with chromosomal abnormalities, prompt postnatal medical and therapeutic support is extremely important:
Medical side
- Early management of congenital heart disease or respiratory problems
- Regular growth and developmental follow‑up
Therapeutic side
- Early initiation of physical therapy, occupational therapy, speech therapy
- Introduction of developmental support programs at home
Education / Welfare side
- Use of regional disability day programs and special support education
- An integrated support system combining medical, welfare, and educational services
If chromosomal anomalies are known before birth, these supports can be activated in a smoother, more coordinated way.
16. Recent Research Trends
Research on chromosomal abnormalities is rapidly evolving:
- The proliferation of whole‑chromosome NIPT enables detection not only of numerical abnormalities but also microdeletions / duplications
- Application of microarray analysis and NGS (next‑generation sequencing)
→ Can detect abnormalities at the scale of hundreds of thousands to millions of base pairs with high precision - Integration with genomic medicine
→ Prenatal diagnosis and postnatal precision medical support are gradually connecting
In the future, combining prenatal diagnosis with postnatal genomic medicine is expected to make developmental support for children more efficient.
17. Points Families Should Be Aware of in Advance
Before undergoing NIPT or chromosomal testing, it is advisable for families to discuss the following:
- What is the purpose of taking the test?
- What will we do if the result is positive?
- What kind of support do we hope for after birth?
Having this preparation means that when test results arrive, the family is not thrown into confusion but can act proactively and thoughtfully.
Conclusion: Understanding Small Chromosomal Abnormalities Can Change the Future
- Chromosomal abnormalities are one of the main causes of intellectual and developmental disabilities
- Even microdeletions / duplications can have significant influence on neurodevelopment
- Prenatal tests such as NIPT can help detect risks early, enabling earlier medical, therapeutic, and family support
- While considering medical advances, it’s equally important to be aware of the social and ethical implications and support structures
- Correct comprehension of chromosomal abnormalities is the first step toward a more secure, comforting future for the child and family
References (Evidence)
Japan Society of Obstetrics and Gynecology: “Guidelines on Prenatal Diagnosis”
Shaffer LG et al., American Journal of Human Genetics, 2007; 80: 605‑616
Miller DT et al., Genetics in Medicine, 2010; 12(11): 742‑755
Xu Y et al., Prenatal Diagnosis, 2020; 40(7): 869‑879
Wilson KL et al., Genetics in Medicine, 2021; 23: 1222‑1231
